These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Levofloxacin-based triple therapy versus bismuth-based quadruple therapy in the treatment of Zhang M; Chen CY; Wang XT; Lyu B Zhonghua Nei Ke Za Zhi; 2017 May; 56(5):368-374. PubMed ID: 28460509 [No Abstract] [Full Text] [Related]
9. Comparison of 10-day levofloxacin bismuth-based quadruple therapy and levofloxacin-based triple therapy for Helicobacter pylori. Wu TS; Hsu PI; Kuo CH; Hu HM; Wu IC; Wang SSW; Chen YH; Wu DC; Su WW; Kuo FC J Dig Dis; 2017 Sep; 18(9):537-542. PubMed ID: 28644575 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis. Marin AC; Nyssen OP; McNicholl AG; Gisbert JP Drugs; 2017 May; 77(7):765-776. PubMed ID: 28361211 [TBL] [Abstract][Full Text] [Related]
11. Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy. Song Z; Zhou L; Zhang J; He L; Bai P; Xue Y Dig Liver Dis; 2016 May; 48(5):506-511. PubMed ID: 26847964 [TBL] [Abstract][Full Text] [Related]
12. [Ten-day Sequential Therapy versus Bismuth Based Quadruple Therapy as Second Line Treatment for Helicobacter pylori Infection]. Kim SB; Lee SH; Kim KO; Jang BI; Kim TN Korean J Gastroenterol; 2015 Nov; 66(5):261-7. PubMed ID: 26586348 [TBL] [Abstract][Full Text] [Related]
13. Novel and Effective Therapeutic Regimens for Hu Y; Zhu Y; Lu NH Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929 [No Abstract] [Full Text] [Related]